Call for
Healthtech India 2026
About Organisation
Swissnex is Switzerland’s global network that bridges education, research, and innovation across borders. Its mission is to foster international collaboration by creating opportunities for the exchange of knowledge, ideas, and talent. With six key locations in some of the world’s most innovative regions, along with over twenty Science and Technology Offices and Counsellors housed in Swiss embassies, Swissnex strengthens Switzerland’s global presence as a hub of innovation. It is an initiative of the Swiss State Secretariat for Education, Research and Innovation (SERI) and operates under the Federal Department of Foreign Affairs.
Since 2010, Swissnex in India, Consulate General of Switzerland, has been pivotal in strengthening Indo-Swiss ties in education, research, and innovation. In 2023, Swissnex in India further expanded its strategic scope through the Indo-Swiss Innovation Platform, focusing on three key areas—health, sustainability, and digital transformation. By connecting Swiss innovators with India’s growing ecosystem, Swissnex facilitates collaborations that drive global impact. Its initiatives provide startups, researchers, and institutions with access to cross-border opportunities, enabling them to test, validate, and scale their innovations in high-growth environments. Through such efforts, Swissnex contributes to building Switzerland’s image as a world-leading innovation hotspot with deep, impactful international engagement.
About the Grant
HealthTech India 2026 is a flagship programme designed to connect Swiss startups in life sciences, medtech, and digital health with India’s rapidly expanding healthcare ecosystem. Managed by Swissnex and powered by Innosuisse, the programme provides startups with a unique platform to validate their products, explore strategic collaborations, and unlock growth opportunities in one of the world’s largest healthcare markets.
The programme spans a one-week on-site camp in India in February 2026, preceded by four to six weeks of preparatory virtual sessions with Swissnex coaches. Startups will participate in bilateral meetings with key Indian healthtech stakeholders, supported by Swissnex’s structured coaching and briefing sessions. A major highlight is the opportunity to showcase innovations at BioAsia 2026, a leading healthcare conference in Hyderabad, providing visibility to global investors and industry leaders.
Participants benefit from travel stipends of CHF 3,000 for Market Validation Camp and CHF 6,000 for Market Entry Camp. Additionally, 15 days of post-visit support ensure startups can follow up on leads and partnerships developed during the programme. With India’s healthcare sector valued at USD 372 billion and projected to grow significantly, the programme offers Swiss startups access to vast patient populations, diverse testing environments, and potential for scalable global impact.
Who can Apply?
The HealthTech India 2026 programme is open to healthtech startups that are legally headquartered in Switzerland. Eligible companies must be incorporated within the last five years and demonstrate strong potential to expand into global markets. Startups should ideally be working in life sciences, medtech, or digital health, with solutions that address pressing healthcare needs.
Applicants are encouraged from early to growth stages, provided they have at least a late-stage prototype developed and are ready for market validation. Preference will be given to startups actively engaged in the Innosuisse Coaching Programme, whether in the initial, core, or scale-up phases. Such startups will benefit from synergies between their ongoing coaching and the opportunities provided through this programme.
The initiative particularly seeks startups with innovations that can be tested in real-world environments, ranging from cost-effective diagnostic solutions for mass populations to high-end personalised healthcare technologies. The programme is designed to support companies that are not only market-ready but also willing to engage with India’s dynamic healthcare ecosystem for co-development and clinical validation. By participating, Swiss startups can position themselves strategically in a high-growth market while contributing to global healthcare transformation through innovation, scalability, and cross-border collaboration.
How to Apply?
Interested Swiss startups can register by completing the official application form. Applicants should clearly highlight their business model, product readiness, and potential impact in India’s healthcare ecosystem. The application must include details on innovation, scalability, and market validation goals. Early submission is encouraged to allow ample time for review and preparation. Successful candidates will be notified directly and guided by Swissnex for the preparatory sessions before the programme.
Application Deadline
Applications for HealthTech India 2026 must be submitted no later than 20 September. Startups are advised to apply early to ensure timely consideration and participation in the preparatory phase.
Last Date to Apply
The final deadline to submit applications for HealthTech India 2026 is 20 September. Late submissions will not be accepted under any circumstances, and shortlisted startups will be notified thereafter.
Grant Amount
Selected startups will receive financial support from Innosuisse, including CHF 3,000 for participation in the Market Validation Camp and CHF 6,000 for the Market Entry Camp.
Last Date To Apply
For more information, please visit the grant website here.
